尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Zannes Maria. Officer active across 1 company, notably bioAffinity Technologies, Inc.. Cumulatively, 8 filings have been published. Breakdown: 1 buy · 0 sell. History available since 1 January 2023. The latest transaction was disclosed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Zannes Maria is linked to bioAffinity Technologies, Inc. as President & CEO. She has 8 filings in total, and across the sampled recent filings from 2022-11-22 to 2025-01-14, the amounts shown are attributed transactions, with 0 in buys and 0 in sells.